These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34342003)

  • 1. Associations between MMPI-3 scale scores and the DSM-5 personality disorders.
    Brown TA; Sellbom M
    J Clin Psychol; 2021 Dec; 77(12):2943-2964. PubMed ID: 34342003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing
    Ghamkhar Fard Z; Pourshahbaz A; Anderson J; Shakiba S; Mirabzadeh A
    Assessment; 2022 Jun; 29(4):782-805. PubMed ID: 33559481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of DSM-5 section II personality disorder constructs using the MMPI-2-RF in clinical and forensic samples.
    Anderson JL; Sellbom M; Pymont C; Smid W; De Saeger H; Kamphuis JH
    Psychol Assess; 2015 Sep; 27(3):786-800. PubMed ID: 25799092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further Examining the Construct Validity of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) Personality Disorder Spectra Scales.
    Kremyar AJ; Ben-Porath YS
    J Pers Assess; 2021; 103(4):443-454. PubMed ID: 33950766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing ICD-11 personality trait domain qualifiers with the MMPI-2-RF.
    Anderson JL; Sellbom M
    J Clin Psychol; 2021 Apr; 77(4):1090-1105. PubMed ID: 33320342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between DSM-5 section III personality traits and the Minnesota Multiphasic Personality Inventory 2-Restructured Form (MMPI-2-RF) scales in a psychiatric patient sample.
    Anderson JL; Sellbom M; Ayearst L; Quilty LC; Chmielewski M; Bagby RM
    Psychol Assess; 2015 Sep; 27(3):801-15. PubMed ID: 25822829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of DSM-5 Section II Personality Disorders With the MMPI-2-RF in a Nonclinical Sample.
    Sellbom M; Smith A
    J Pers Assess; 2017; 99(4):384-397. PubMed ID: 27849364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing DSM-5 section III personality traits and disorders with the MMPI-2-RF.
    Sellbom M; Anderson JL; Bagby RM
    Assessment; 2013 Dec; 20(6):709-22. PubMed ID: 24220212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between MMPI-3 Scale Scores and the
    Brown TA; Sellbom M
    Assessment; 2023 Jun; 30(4):943-958. PubMed ID: 35144481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MMPI-2 Restructured Form Personality Psychopathology Five Scales: bridging DSM-5 Section 2 personality disorders and DSM-5 Section 3 personality trait dimensions.
    Finn JA; Arbisi PA; Erbes CR; Polusny MA; Thuras P
    J Pers Assess; 2014; 96(2):173-84. PubMed ID: 24377431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of MMPI-2-RF Personality Disorder Spectra scales in a psychiatric sample.
    Sellbom M; Brown TA; Bagby RM
    Psychol Assess; 2020 Mar; 32(3):314-320. PubMed ID: 31789539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the convergence between PSY-5 domains and PID-5 domains and facets: implications for assessment of DSM-5 personality traits.
    Anderson JL; Sellbom M; Bagby RM; Quilty LC; Veltri CO; Markon KE; Krueger RF
    Assessment; 2013 Jun; 20(3):286-94. PubMed ID: 23297369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Response Bias on the Personality Inventory for DSM-5 (PID-5).
    McGee Ng SA; Bagby RM; Goodwin BE; Burchett D; Sellbom M; Ayearst LE; Dhillon S; Yiu S; Ben-Porath YS; Baker S
    J Pers Assess; 2016; 98(1):51-61. PubMed ID: 26583767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Personality Disorder Spectra Scales for the MMPI-2-RF.
    Sellbom M; Waugh MH; Hopwood CJ
    J Pers Assess; 2018; 100(4):406-420. PubMed ID: 29319367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and initial validation of Personality Disorder Syndrome scales for the MMPI-3.
    Sellbom M; Brown TA; Waugh MH; Hopwood CJ
    Psychol Assess; 2024 May; 36(5):323-338. PubMed ID: 38695789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and extension of personality disorder spectra scales from MMPI-2-RF items.
    Hale AC; Nelson SM; Reckow J; Spencer RJ
    J Clin Psychol; 2020 Sep; 76(9):1754-1774. PubMed ID: 32242930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the MMPI-2-RF to Assess Risk of Nonsuicidal Self-Injury among College Students.
    Whitman MR; Kremyar AJ; Ben-Porath YS
    J Pers Assess; 2021; 103(4):455-464. PubMed ID: 32783548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental validity of the MMPI-2 PSY-5 scales in assessing self-reported personality disorder criteria.
    Wygant DB; Sellbom M; Graham JR; Schenk PW
    Assessment; 2006 Jun; 13(2):178-86. PubMed ID: 16672732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between MMPI-2-RF validity scale scores and extra-test measures of personality and psychopathology.
    Forbey JD; Lee TT; Ben-Porath YS; Arbisi PA; Gartland D
    Assessment; 2013 Aug; 20(4):448-61. PubMed ID: 23443819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criterion A of the DSM-5 Alternative Model for Personality Disorders in MMPI-2/RF Personality Disorder Scales.
    Waugh MH; Mulay AL; Crittenden EB; Rossi G
    Front Psychol; 2021; 12():735848. PubMed ID: 34899478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.